Related Experiment Videos
Protective effect of ginsenoside Rg1 on dopamine-induced apoptosis in PC12 cells
1Fujian Institute of Geriatrics, Union Hospital, Fujian Medical Univisity, Fuzhou 350001, China. ZJCXCH@Public5.FZ.FJ.cn
Acta Pharmacologica Sinica
|December 26, 2001
Summary
Ginsenoside Rg1 protects PC12 cells from dopamine-induced apoptosis by inhibiting caspase-3 activation and altering Bcl-2/Bax protein ratios. This study explores the molecular mechanisms of this protective effect.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Exogenous dopamine can induce apoptosis in PC12 cells, a neuronal cell model.
- Ginsenoside Rg1 is a natural compound with potential protective properties.
Purpose of the Study:
- To investigate the molecular mechanisms underlying dopamine-induced apoptosis in PC12 cells.
- To evaluate the protective effects of ginsenoside Rg1 against dopamine-induced cell death.
Main Methods:
- Flow cytometry was used to assess apoptosis and protein expression (Bcl-2, Bax).
- Transmission electron microscopy examined apoptotic morphology.
- DNA fragmentation, caspase-3 activity, and mRNA expression (bcl-2, bax) were analyzed.
Main Results:
- Dopamine induced dose-dependent apoptosis in PC12 cells.
- Ginsenoside Rg1 pretreatment significantly reduced dopamine-induced apoptosis and caspase-3 activity.
- Rg1 treatment modulated Bcl-2 and Bax protein expression, shifting the ratio favorably.
Conclusions:
- Ginsenoside Rg1 demonstrates a protective effect against dopamine-induced PC12 cell apoptosis.
- The mechanism involves inhibiting caspase-3 activation and regulating the Bcl-2/Bax protein ratio.